of MET4 also suppressed the lethality of temperature
. The by inappropriate accumulation of their known target procritical target of SCF
Met30 is the transcription factor teins, the essential function of SCF Met30 is not known.
Met4, as deletion of MET4 suppresses the lethality of
Temperature sensitive met30 mutants arrest with both met30 mutants. Surprisingly, Met4 is a relatively stable 1N and 2N DNA content. However, the cell cycle arrest protein and its abundance is not influenced by Met30.
is not due to the known defect in Swe1 degradation, However, transcriptional repression of Met4 target because deletion of SWE1 does not suppress the lethalgenes correlates with Cdc34 /SCF Met30 -dependent ubiity or cell cycle arrest associated with met30 mutation quitination of Met4. Functionally, ubiquitinated Met4 (Kaiser et al., 1998).
MET30 was initially identified in a screen for S. cerevisassociates with target promoters but fails to form iae mutants defective in the regulation of genes involved functional transcription complexes. Our data reveal a in sulfur amino acid metabolism (Thomas et al., 1995). novel proteolysis-independent function for Cdc34/SCF
Specifically, yeast strains harboring a semi dominantand indicate that ubiquitination of transcription factors negative allele of MET30 failed to repress MET25 trancan be utilized to directly regulate their activities.
scription in the presence of high levels of methionine. Subsequently, it has been demonstrated that this failure to respond to repressing levels of methionine is due to Introduction a defect of Met30 in the context of SCF Met30 because cdc34, skp1, and cdc53 mutants also fail to repress Ubiquitination of proteins plays a major role in regulation MET25 transcription (Patton et al., 1998). Transcription of cellular processes. The best studied function of ubiof MET25 and a number of other genes involved in sulfur quitination is its role in protein degradation, where polyamino acid metabolism (MET genes) depends on the ubiquitinated proteins are recognized by the 26S proteatranscriptional activator Met4. some and rapidly degraded. However, ubiquitin is also We show here that inability to downregulate Met4 activattached to stable proteins, most notably to a number ity accounts for the cell cycle arrest phenotype associated of cell surface receptors, where ubiquitination in rewith met30 mutants. Mechanistically, Cdc34/SCF Met30 -sponse to ligand binding serves as an internalization mediated ubiquitination of Met4 leads to its inactivation. signal. In either case, ubiquitination of target proteins Met4 ubiquitination, however, does not induce its degrais catalyzed by a cascade of enzymatic reactions. Ubidation by the 26S proteasome, but rather results in direct quitin is first activated in an ATP dependent step by E1 inhibition of its activity as a transcriptional activator. enzymes, and the activated ubiquitin is then transferred to a specific cysteine residue on one of a family of ubiquiResults
tin-conjugating enzymes (E2). E2 enzymes can directly ubiquitinate target proteins but often require factors (E3
Deregulation of MET4 Causes Cell Cycle Arrest enzymes or ubiquitin-protein ligases) that confer subin met30 Mutants strate specificity. The SCF complexes, probably the best MET30 is an essential gene in S. cerevisiae. When temstudied class of E3 enzymes, consist of the three core perature sensitive met30 mutants are shifted to the recomponents Skp1, Cdc53 (in yeast), or Cul-1 (in mamstrictive temperature, they arrest as both unbudded and malian cells) and one member of the F-box protein fambudded cells with 1N and 2N DNA content, respectively ily. The F-box protein subunit of SCF directly binds sub- (Kaiser et al., 1998) . It has been reported that deletion strates (Ciechanover, 1998; Hershko and Ciechanover, of MET4 bypasses the cell cycle arrest associated with 1998; Koepp et al., 1999) . met30 mutations (Patton et al., 1998). We obtained simiThree other proteins that are important for SCF funclar results in our strain background. Tetrad analysis retion have been shown to directly associate with SCF vealed that the double mutant met4 met30 is viable complexes, namely Cdc34, Rbx1/Hrt1 and Sgt1 (Kamura ( Figure 1A ) whereas the met30 single mutant germinated but arrested in the first cell cycle as an unbudded (about 70%) or large budded cell (data not shown). Deletion ‡ To whom correspondence should be addressed (e-mail: sreed@ scripps.edu).
of MET4 also suppressed the lethality of temperature
Met30-and Cdc34-Dependent Modification of Met4 Correlates with Met4 Activity
The genetic analysis suggested that Met4 is hyperactive in met30 mutants. Since Met30 is a component of SCF, which is thought to function exclusively in ubiquitinmediated protein degradation, we asked whether Met4 levels were increased in met30 mutants. Met30 was inactivated in a temperature sensitive met30-6 mutant by shifting to 37ЊC and we compared levels of myc-epitope tagged Met4 expressed from the endogenous promoter in wild-type and met30 mutant cells at 25ЊC and 37ЊC (Figure 2A ). No increase in the level of Met4 was observed in the met30 mutant strain at the restrictive temperature ( Figure 2A ). However, we observed a dramatic difference in Met4 modification in wild-type cells and met30 mutants (Figure 2A and MET28) that are known to be controlled by Met4 ⌬cbf1 (PY640), and ⌬cbf1 met30-6(PY667)).
activity (Thomas and Surdin, 1997). In methionine-containing medium, expression of MET16, MET25, and sensitive met30-6 mutants at all temperatures tested (Fig-MET28 is repressed (Thomas and Surdin, 1997). Accordure 1A). These genetic results suggest that met30 mutants ingly, we detected only very low levels of these mRNAs arrest due to hyperactive Met4. Accordingly, overexpresin wild-type cells at both 25ЊC and 37ЊC (Figure 2A ). In sion of Met4 in temperature sensitive met30-6 mutants, contrast, MET16, 25, and 28 expression was derebut not in wild-type cells, resulted in a growth defect pressed in met30-6 mutants, even in methionine-coneven at permissive temperature (25ЊC) (Figure 1B) , sugtaining medium (Figure 2A ). Overexpression of Met4 in gesting that met30 mutants are particularly sensitive to wild-type cells only modestly derepressed MET16, 25, Met4 levels. and 28 expression (Figure 2A ), suggesting their expresMet4 is a transcriptional activator that is required for sion is not regulated at the level of Met4 abundance. expression of many genes involved in sulfur amino acid We then analyzed Met4 modification during methiometabolism. The basic helix-loop-helix protein Cbf1 is nine starvation. Expression of MET genes is repressed another important transcription factor that acts in conin medium containing methionine. However, when mecert with Met4 in activation of MET genes. Deletion of thionine is withdrawn, expression is rapidly induced CBF1 results in a phenotype of methionine auxotrophy, (Thomas and Surdin, 1997). When we shifted wild-type slow growth, and chromosome instability (Cai and Davis, cells to growth medium without methionine we observed 1990). Deletion of CBF1 partially suppressed loss of a rapid change in Met4 modification ( Figure 2B ). The Met30 function, as indicated by a higher restrictive temMet4-A and Met4-B forms decreased, whereas Met4-E perature for cbf1 met30-6 double mutants compared to accumulated ( Figure 2B ). This change correlated with met30-6 single mutants ( Figure 1C) , indicating that the Met4 activity as indicated by induction of MET16, lethality of met30 mutants is related to the transcrip-MET25, and MET28 ( Figure 2B Figure 2C ). In contrast, we saw in wild-type cells and met30 mutants. Fully functional C-terminal myc-epitope-tagged Met4 (Figures 2 and 6 ) no such change in Met4 mobility in cdc4 mutants defective in a heterologous SCF complex ( Figure 2C ), although was expressed for 30 min from the GAL1 promoter in either wild-type cells or met30 mutants following a shift they arrested at the same cell cycle position as cdc34 mutants. Consistent with the strong correlation between to 37ЊC to inactivate the temperature sensitive met30-6 allele. Samples were taken over a period of 100 min Met4 modification and Met4 activity (Figures 2A and B) , MET16, 25, and 28 expression was deregulated in cdc34 after repression of the GAL1 promoter. Western blot analysis revealed that Met4 degradation was very slow mutants but not in cdc4 mutants ( Figure 2C ). Taken together, these results suggest that Cdc34/SCF Met30 acand not impaired in met30 mutants ( Figure 3A) . However, we noticed a striking change in Met4 modification in tivity is required for modification and inactivation of Met4 but not for Met4 degradation.
met30 mutants as compared to wild-type cells (Figure 1, 2, and 3) . Partially purified SCF Met30 (lanes 4, 5, and 6) or "mock purified extract" (lanes 7 and 8) were added to the reaction mix. In lanes 9-12, reactions including yeast E1, Cdc34, ubiquitin, an ATP regenerating system, and either partially purified SCF Met30 (lanes 9 and 10) or "mock purified extract" (lanes 11 and12) are shown. As a reference, Met4-myc detected in a wild-type cell extract is shown (lane 13). All reactions were analyzed by Western blotting (7.5% gel). were incubated with a biotinylated MET25 promoter fragment. We then purified the promoter fragment on type cells ( Figure 6D) . In met30 mutants, where MET gene transcription is constitutively active, the entire pool strepavidin beads and analyzed associated proteins by Western blotting. Cbf1 and all forms of Met4 bound to of Met4 was in the unubiquitinated form. This suggested that the nonubiquitinated forms of Met4 (Met4-D and -E) the MET25 promoter ( Figure 7A ). We detected no bias for any of the various forms of Met4, suggesting that are transcriptionally active whereas the ubiquitinated forms are inactive, as predicted by earlier experiments Met4 association with MET promoters is not regulated by ubiquitination. (Figure 2) . Taken together, these results suggest that ubiquitinaSince the results obtained in the ChIP assays strongly suggested that ubiquitination of Met4 prevents Cbf1 tion of Met4 prevents Cbf1 association with the promoter regions at levels sufficient to promote tranassociation with MET promoters, we directly analyzed Cbf1/Met4 protein interaction. We incubated recombiscription.
Met4 Ubiquitination Prevents Cbf1 Accumulation

specific interaction of Cbf1-HA with Gst-Cbf1 (data not shown).
This experiment demonstrated that interaction of Met4-A with Cbf1 was dramatically and specifically reduced, whereas the other ubiquitinated forms of Met4 (Met4-B and C) associated with Cbf1. These results are consistent with our findings that ubiquitination of Met4 correlates with low Cbf1 binding at MET promoters in vivo (Figure 6 ). However, since the Cbf1/Met4-A interaction was specifically impaired, we would expect that Met4-A is the inactive form of Met4 and that the majority of Met4 should be fully ubiquitinated under fully repressed conditions. Although it is very difficult to preserve the ubiquitinated forms of Met4 during cell lysis and extract preparation due to nonspecific deubiquitination, using protein extraction methods that minimize nonspecific loss of ubiquitination, we find that the majority of Met4 is indeed in the inactive Met4-A form ( Figure  7C ). This validates the biological significance of the Cbf1/Met4 binding studies described above.
Discussion
A Proteolysis-Independent Function for Cdc34/SCF
The results presented in this report suggest a degradation-independent, regulatory function for Cdc34/ SCF have been reflected in changes in total Met4 levels. Therefore, we asked whether Met4 proteolysis might be restricted to MET promoters and, if so, whether local nant Gst-Cbf1 bound to glutathione beads with cell lyregulation of Met4 abundance at MET promoters regusates prepared from wild-type cells expressing endogelated MET gene transcription. ChIP assays demonnous Met4-myc and Cbf1-HA. A small fraction of Met4-strated that Met4 association with MET promoters was myc (1%-5%) was specifically retained on Gst-Cbf1 constant regardless of the regulatory status of the probeads ( Figure 7B) . Interestingly, proportionally much moters ( Figures 6B and 6C) . Hence, proteolysis of the less Met4-A, the most ubiquitinated form of Met4, inter-MET promoter-associated Met4 pool was not responsible for transcriptional regulation. Taken together, these acted with Gst-Cbf1 ( Figure 7B) . We also detected a 2A and 2C; Figure 6A) (Patton et al., 1998, Seol et al.,  1999) .
In an attempt to understand how Met4 ubiquitination regulates MET gene transcription, we analyzed the events at two distinct MET promoters (MET16 and MET25) during activation and rerepression. Surprisingly, Met4 binding at both promoters was unchanged during transcriptional induction and rerepression ( Figure 6B) . However, Cbf1 association was tightly correlated with transcriptional activity and, in an inverse manner, with Met4 ubiquitination (Figure 6 ). This suggests that Cbf1 recruitment to MET promoters leads to their activation Our data are consistent with Met4 acting either to promote or, in its ubiquitinated form, to inhibit association of Cbf1 with the MET promoters. To decide whether ubiquitinated Met4 functions as an active repressor or is simply inactive as a transcription factor will require further investigation.
As pointed out above, Cbf1 is also a component of the yeast kinetochore. As with MET gene transcription, kinetochore function appears to be controlled by ubiquitination, in this case, of the kinetochore protein Cbf2. It We suggest that such a cell cycle arrest would be linked 
Yeast Strains and Methods
The relevant genotypes of the yeast strains used in this study are Analysis of Met4 Turnover Met4-myc:wild-type cells and met30-6 mutants containing an intelisted in Table 1 . All strains are isogenic to 15Daub⌬, a bar1⌬ ura3⌬ns, derivative of BF264-15D (Reed et al., 1985) . All strains grated GAL1-MET4(myc18) allele (PY742, PY760) were grown in raff/-leu medium (supplemented with 5mM methionine) at 25ЊC to were grown in standard culture media and standard yeast genetic methods were used (Guthrie and Fink, 1991).
an OD 600 ϭ 0.3. Cells were then shifted to 37ЊC and after 15 min galactose was added to a final concentration of 2% to induce the In most experiments involving protein analyses, strains harboring a deletion of PEP4 were used. Deletion of PEP4 did not alter Met4 GAL1 promoter. To terminate Met4 expression after 30 min, cells were collected on filters and transferred to dex/-leu medium (supplemodification or change any other result, however the experiments were more reliable because nonspecific proteolysis during extract mented with 5mM methionine, prewarmed to 37ЊC) and incubation was continued at 37ЊC. Extracts were prepared in 50 mM Tris-HCl preparation and immunoprecipitation was decreased in pep4 mutants.
(pH. concentration was 2 g/l for both SCF Met30 and the "mock-purificagrown in YEPD at 30ЊC to an OD 600 ϭ 0.3. Cultures were shifted to tion", indicating that the majority of proteins were nonspecifically 37ЊC for 2 hr, protein extracts were prepared in RIPA-buffer plus 5 bound to Ni-NTA-agarose. To prepare Met4 substrate for in vitro mM N-ethylmaleimide and Met4-myc was immunoprecipitated from ubiquitination assays, met30 mutants expressing Met4-myc (PY743) 2.5 mg protein with polyclonal antibodies directed against the mycwere grown at 37ЊC for 3.5 hr. Cells were broken in buffer B150, 15 epitope (Santa Cruz Biotechnology). Immune complexes were mg of protein was incubated with polyclonal antibodies directed washed twice with 1 ml RIPA buffer, twice with 1 ml RIPA buffer against the myc epitope (Santa Cruz Biotechnology) and proteinA without phosphatase inhibitors (␣-Ph), and once in 1 ml 50 mM Trisbeads for 2 hr at 4ЊC. Immune complexes were washed 2 times with HCl (pH 7.5), 5 mM DTT, and 0.1 mg/ml BSA. Immunopurified Met4 2 ml buffer B150 and 2 times with 1 ml YEB. Met4-substrate bound was split into three equal parts. One part was incubated in 100 l to beads was equally distributed between the in vitro ubiquitination phosphatase reaction mix (50 mM Tris-HCl [pH 7.5], 5 mM DTT, 0.1 reactions. In vitro ubiquitination reactions contained 5 mM Mg acemM EDTA, 0.01% Brij35, and 2 mM MnCl 2 ) without phosphatase.
tate, 1 g/ml aprotinin, leupeptin and pepstatin A, 1mM DTT, an ATP The two other parts were incubated with phosphatase reaction mix regenerating system (Kaiser et al., 1999), 2 g/ml bovine ubiquitin and 1200 units lambda-phosphatase (NEB), but to one of them a (Sigma), recombinant Cdc34 (40 g/ml), purified yeast E1 (15 g/ phosphatase inhibitor cocktail (␣-Ph) was added. The reactions were ml) and, as indicated, 5 mg/ml whole cell extract prepared from incubated at 30ЊC for 60 min, and the immunocomplexes were met30-6 mutants, and/or 1 mg/ml partially purified SCF . PCR fragments were separated on and ␣-Pr). DTT concentration was adjusted to a final concentration a 2.5% agarose gel and visualized by ethidium bromide. of 5 mM and 1 mg protein was incubated for 2 hr at 4ЊC with 50 l glutathione-Sepharose. The beads were washed 4 times with 1 ml B150 ϩ 5 mM DTT, bound proteins were eluted in 150 l 2ϫ SDS DNA-Affinity Purification sample buffer and analyzed by Western blotting. Met4 was detected Cells were grown in YEPD to an OD 600 ϭ 0.5, shifted to 37ЊC for 2 with 9E10 antibodies, and Gst or Gst-fusion proteins were detected hr, and extracts were prepared from approximately 3 ϫ 10 7 cells in with polyclonal antibodies directed against Gst. 2ϫ buffer D1 (buffer D1: 50 mM HEPES [pH 7.5], 0.5 M NaCl, 5 mM MgCl 2 , 1 mM DTT, 0.5% Triton X-100, ␣-Pr, 0.1mM orthovanadate, and 10mM pyrophosphate). The cleared lysate was diluted 1:10 with Met4 In Vitro Ubiquitination Extracts for in vitro ubiquitination were prepared from met30-6 mubuffer D2 (50 mM HEPES [pH 7.5], 5 mM MgCl 2 , 1 mM DTT, ␣-Pr, 0.1 mM orthovanadate, and 10 mM pyrophosphate). Five milligrams tants (PY286) as described (Kaiser et al., 1998) . SCF Met30 was partially purified from a ⌬met30 deletion strain expressing RGS6H-tagged of total protein was incubated with 1 g/ml either biotinylated PCR MET25 promoter fragment or a biotinylated PCR control fragment. Met30 from the GAL1 promoter (PY401). An isogenic wild-type strain expressing untagged Met30 (PY236) was used for the "mock-purifiThe PCR fragments were obtained with the same primer sequences as used for the ChIP assay, but the 5Ј primer was biotinylated. After cation". Cells were grown at 30ЊC in YEPGal to an OD 600 ϭ 1.5. To 7.5 ml cell pellet, 12.5 ml 2ϫ buffer NM (1ϫ NM: 50 mM sodium incubation for 2 hr at 4ЊC, 100 l Strepavidin MagneSphere beads 
